BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Robinson S, Thomas R. Potential for Antigen-Specific Tolerizing Immunotherapy in Systematic Lupus Erythematosus. Front Immunol 2021;12:654701. [PMID: 34335564 DOI: 10.3389/fimmu.2021.654701] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 mohammadi B, saghafi M, Abdulsattar Faraj T, Kamal Kheder R, Sajid Abdulabbas H, Esmaeili S. The role of tolerogenic dendritic cells in systematic lupus erythematosus progression and remission. International Immunopharmacology 2023;115:109601. [DOI: 10.1016/j.intimp.2022.109601] [Reference Citation Analysis]
2 Lazar S, Kahlenberg JM. Systemic Lupus Erythematosus: New Diagnostic and Therapeutic Approaches. Annu Rev Med 2023;74:339-52. [PMID: 35804480 DOI: 10.1146/annurev-med-043021-032611] [Reference Citation Analysis]
3 Xiang S, Zhang J, Zhang M, Qian S, Wang R, Wang Y, Xiang Y, Ding X. Imbalance of helper T cell type 1, helper T cell type 2 and associated cytokines in patients with systemic lupus erythematosus: A meta-analysis. Front Pharmacol 2022;13:988512. [DOI: 10.3389/fphar.2022.988512] [Reference Citation Analysis]
4 Smith TJ. Understanding Pathogenesis Intersects With Effective Treatment for Thyroid Eye Disease. J Clin Endocrinol Metab 2022;107:S13-26. [PMID: 36346686 DOI: 10.1210/clinem/dgac328] [Reference Citation Analysis]